Bio-Rad Laboratories Inc (BIO-B)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $10.49B
Last updated: Nov 16, 2026 at 4:10 PM ET
Bio-Rad Laboratories Inc (BIO-B) P/E Ratio & Valuation History
Bio-Rad Laboratories (BIO-B) trades at 10.3x trailing earnings and 4.1x sales. Its P/E of 10.3x is below its 10-year median of 46.7x. Its forward P/E is 40.8x. The median P/E across 9 similar companies is 23.9x.
Current Multiples
Its forward P/E is above its trailing P/E, which implies earnings per share about 74.8% lower over the next year. Its free cash flow yield is 3.1%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 10.3x |
| Forward P/E | 40.8x |
| Price to sales | 4.1x |
| Price to book | 1.4x |
| EV/EBITDA | 7.6x |
| Price to FCF | 31.9x |
| EV/FCF | 34.2x |
| PEG | 1.2 |
| FCF yield | 3.1% |
Historical Medians
Against its 10-year medians, its P/S is 7.9% above 3.8x and its P/B is 12.5% below 1.6x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 10.3x | N/A | 46.7x |
| P/S | 4.1x | 3.7x | 3.8x |
| P/B | 1.4x | 1.2x | 1.6x |
Valuation History
Over the 9 of the 10 year ends shown that have a P/E, its P/E ranged from 11.1x in 2025 to 192.8x in 2016. 2025 was the lowest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $310.70 | 11.1x | 3.3x | 1.1x |
| 2024 | $325.60 | N/A | 3.6x | 1.4x |
| 2023 | $320.65 | 27.2x | 3.5x | 1.1x |
| 2022 | $404.66 | 28.4x | 4.3x | 1.3x |
| 2021 | $722.91 | 46.1x | 7.5x | 1.6x |
| 2020 | $574.15 | 54.5x | 6.8x | 1.8x |
| 2019 | $369.60 | 51.7x | 4.8x | 1.9x |
| 2018 | $230.00 | 39.3x | 3.0x | 1.7x |
| 2017 | $238.25 | 118.5x | 3.3x | 2.4x |
| 2016 | $183.15 | 192.8x | 2.6x | 2.1x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About BIO-B
What is BIO-B's forward P/E ratio?
Bio-Rad Laboratories has a forward P/E ratio of 40.8x.
Is BIO-B stock overvalued?
GNG's valuation label for BIO-B is Undervalued. Its P/E of 10.3x compares with a median of 23.9x across 9 similar companies.
What is BIO-B's price to sales ratio?
Bio-Rad Laboratories has a price to sales ratio of 4.1x.
What is Bio-Rad Laboratories's average P/E ratio over 10 years?
Bio-Rad Laboratories's median P/E over the last 10 years is 46.7x, from 105 month-end values through Oct 2026.
What is BIO-B's PEG ratio?
Bio-Rad Laboratories has a PEG ratio of 1.2.
BIO-B pages: Overview, Earnings, Financials, Valuation, Competitors